Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

BA
'Boeing Fails to Overturn Revived $72 Million Trade Secrets Loss' - Bloomberg Law

'Boeing Fails to Overturn Revived $72 Million Trade Secrets Loss' - Bloomberg Law...

JPM
Banks Fought Stablecoins For Years, JPMorgan Now Evaluates Its Own: 'We Would Evaluate All Options'

Banks Fought Stablecoins For Years, JPMorgan Now Evaluates Its Own: 'We Would Evaluate All Options'...

CRM
Salesforce Raises FY2027 GAAP EPS Guidance from $7.93-$7.99 to $10.21-$10.25 vs $8.16 Est

Salesforce Raises FY2027 GAAP EPS Guidance from $7.93-$7.99 to $10.21-$10.25 vs $8.16 Est...

CRM
Salesforce Sees Q3 GAAP EPS $1.81-$1.83 vs $1.90 Est

Salesforce Sees Q3 GAAP EPS $1.81-$1.83 vs $1.90 Est...

CRM
Salesforce Raises FY2027 Adj EPS Guidance from $14.06-$14.12 to $16.67-$16.71 vs $14.14 Est; Raises FY2027 Sales Guidance from $45.900B-$46.200B to $46.100B-$46.400B vs $46.111B Est

Salesforce Raises FY2027 Adj EPS Guidance from $14.06-$14.12 to $16.67-$16.71 vs $14.14 Est; Raises FY2027 Sales Guidance from $45.900B-$46.200B to $4...

CRM
Salesforce Sees Q3 Adj EPS $3.42-$3.44 vs $3.37 Est; Sees Sales $11.420B-$11.500B vs $11.407B Est

Salesforce Sees Q3 Adj EPS $3.42-$3.44 vs $3.37 Est; Sees Sales $11.420B-$11.500B vs $11.407B Est...

CRM
Salesforce Q2 Adj. EPS $5.90 Beats $3.27 Estimate, Sales $11.345B Beat $11.320B Estimate

Salesforce Q2 Adj. EPS $5.90 Beats $3.27 Estimate, Sales $11.345B Beat $11.320B Estimate...

CRM
Salesforce, Anthropic Announcing Claudeforce Collaboration

Salesforce, Anthropic Announcing Claudeforce Collaboration...

CRM
Salesforce shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also, the company raised its FY27 guidance.

Salesforce shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also...

CRM
Salesforce Says Final Settlement Of $25B Accelerated Share Repurchase Expected In October 2026; With U.S. Dollar Strengthening In Q2, Salesforce Now Expects Reduced Currency Tailwind For Business Relative To Prior Guidance; On Track For Second-Half Organic Revenue Reacceleration

Salesforce Says Final Settlement Of $25B Accelerated Share Repurchase Expected In October 2026; With U.S. Dollar Strengthening In Q2, Salesforce Now E...

IREN
IREN Q4 Preview: Stock Down 48% From Highs, Will Data Center Monetization Shine Through in Earnings?

IREN Q4 Preview: Stock Down 48% From Highs, Will Data Center Monetization Shine Through in Earnings?...

CRM
Salesforce Stock Soars On Q2 Double Beat, 'Claudeforce' Anthropic Partnership

Salesforce Stock Soars On Q2 Double Beat, 'Claudeforce' Anthropic Partnership...

OKTA
12 Information Technology Stocks Moving In Wednesday's After-Market Session

12 Information Technology Stocks Moving In Wednesday's After-Market Session...

NVDA
NVIDIA CFO Says We Have Invested $50B In Frontier Labs; OpenAI's Existing, Planned Commitments Represent Around 12GW Of NVIDIA Compute

NVIDIA CFO Says We Have Invested $50B In Frontier Labs; OpenAI's Existing, Planned Commitments Represent Around 12GW Of NVIDIA Compute...

MSFT
Here’s How Much You Would Have Made Owning Microsoft Stock In The Last 20 Years

Here’s How Much You Would Have Made Owning Microsoft Stock In The Last 20 Years...

CRM
$100 Invested In Salesforce 20 Years Ago Would Be Worth This Much Today

$100 Invested In Salesforce 20 Years Ago Would Be Worth This Much Today...

SUN
FDA Approves Unknown Drug — SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED announced the United States FDA approval of its latest medication on August 26, marking a strategic entry into t...

Revolution
FDA Approves RASONQUE — Revolution Medicines, Inc.

Revolution Medicines today achieved a significant strategic milestone with the FDA approval of NDA220910 for DARAXONRASIB (oral), a development that b...

13F-HR/A
13F-HR/A - Advisors Asset Management, Inc. (0001297376) (Filer)

Institutional holdings report (13F-HR) filed by 13F-HR/A - Advisors Asset Management, Inc. (0001297376) (Filer)....

13F-HR/A
13F-HR/A - Advisors Asset Management, Inc. (0001297376) (Filer)

Institutional holdings report (13F-HR) filed by 13F-HR/A - Advisors Asset Management, Inc. (0001297376) (Filer)....